Vita Therapeutics is a cell engineering company that develops life-transformative treatments. Founded by Douglas Falk and Peter Andersen in 2018, Vita Therapeutics is backed by investors that include SCM Life Sciences, Cambrian Biopharma, and Early Light Ventures and is headquartered in Baltimore.